Vets Often Forgo Medication When Co-Pays Rise -- When the co-payment amount
for prescription drugs goes up, veterans prescription medicines tend to stop taking needed
medications, a new study has found. "In this era of large federal budget nexium dosing deficits, it is clear that there
will be ongoing pressure to reduce or at least constrain intense pulsed light hair removal price growth of the VA
budget, and one of the approaches that the Congress may take to cut costs
is through prescription medicines increases in VA prescription co-payments," Doshi said. More information
For more about VA health-care male pattern baldness diet benefits, visit the U.S. "Of even greater concern was our finding that a similar adverse effect
of the co-payment increase was observed in groups at higher risk for
coronary heart disease who were using these medications tramadol online cheap for either primary
or secondary prevention," Doshi said. The co-pay amount was contraception methods iud increased again in 2006, to $8, chemist Doshi said. "Even a seemingly modest
increase in the cost of vital medications discourages many patients from
taking medications that we know prevent heart attacks accutane reviews acne and strokes."
The finding "adds further evidence that Americans need full coverage,
without co-payments plan-b or deductibles, if we are to realize the full promise
of today's medical advances," she stressed. The
study looked at what happened when co-pay amounts were increased earlier
this decade.
"specifically, lower patient
co-payments for higher expected high dose amoxicillin for otitis media therapeutic benefit and higher co-payments
for lower therapeutic contraceptive pills benefit." She called that idea "a more promising
approach." Dr. And
several presidential budget proposals, including the 2008 plan, included a
co-payment increase to $15 for a 30-day supply, she said. "While these proposals were not incorporated into legislation, it is
likely they might be in the future," Doshi said. "This is particularly relevant in the ramon of cholesterol-lowering chemist
medications such as statins, wherein two brand-name statins have become
available as generics since 2006 and are available gemfibrozil 600 price at significantly lower
prices to the Department of Veterans Affairs," Doshi said "Presumably, the
VA could charge veterans lower co-payments for such medications and
thereby facilitate higher adherence with drugs from such essential
medication classes." For the study, Doshi and her fellow levonorgestrel researchers collected data on 5,604
veterans taking cholesterol-lowering drugs prescribed by best pain meds the Philadelphia
VA Medical Center from November 1999 to April 2004.
Department
of Veterans Affairs.. "Policymakers must
consider the findings and implication of studies such as ours in future
policy reform initiatives." Co-pay amounts are the same whether a drug drugstore online usa is a generic or a brand-name
medication, she said. In 2002, it found, many veterans went without needed medication after
the VA (Department of Veterans Affairs) raised co-payments from $2 to $7
for a month's supply of a prescription drug.
"This decline in adherence was not just a result of short gaps in use
interspersed between prescription refills," escitalopram oxalate said Jalpa A. In addition, the odds of being without medication for more than three
months was three times higher during this time among veterans who had to
make co-pays than among those exempt from the payments, the study
found. Issue of the journal tamiflu price usa Circulation,
University of Pennsylvania researchers found that adherence to medication
dropped more than 19 percent among veterans who had to make co-payments
when that amount was increased in 2002. Mela Woolhandler, an associate professor of medicine at Harvard
Medical School, said she thinks the study highlights the need for reform
that would make medical treatment and medication available to all. Because of this, she said, "policymakers need to pay particular
attention to the fact that a 'one-size-fits-all' approach to designing
cost-sharing policies may adversely affect certain higher-risk
patients." As an alternative to an across-the-board increase, Doshi suggested
linking co-payments to individual needs. Doshi, a
research assistant professor of medicine at the University of Pennsylvania
and lead "In fact, the co-payment increase was
accompanied by a significant increase in the likelihood of having
continuous gaps of 90 days or more in lipid-lowering medication use." The finding is diclofenac sodium enteric coated tablets of particular importance today, Doshi indicated, because
of efforts being made to save federal dollars.
Besides the overall drop in adherence rates, the researchers detected a
decline among a particular group of veterans. By comparison, medication
adherence dropped by only 12 percent among veterans who were exempt from
co-pays. They compared veterans who had to make co-payments with similar
veterans who were exempt from prescription drug co-payments, and they
looked at adherence to cholesterol-lowering drugs in the two years before
and the two years after the co-pay increase. "This paper provides striking evidence that co-payments for medications
are potentially lethal," Woolhandler said.
.